Upside | ||||||
---|---|---|---|---|---|---|
6160 | 4.74% | aa.aa | 182.60 | +3.16% | 6,900 | |
MRNA | 4.72% | aa.aa | 27.64 | +0.13% | 4,965 | |
INCY | 4.54% | aa.aa | 78.04 | +3.24% | 1,981 | |
REGN | 4.54% | aa.aa | 571.54 | +2.27% | 277 | |
Twist Bioscience Corp | - | 4.44% | aa.aa | - | - | 4,319 |
Arcellx Inc | - | 4.24% | aa.aa | - | - | 2,002 |
AZN | 4.22% | aa.aa | 11,136.0 | +0.29% | 934 | |
MRK | 4.17% | aa.aa | 79.86 | +0.72% | 1,726 | |
GMAB | 4.11% | aa.aa | 1,414.0 | +1.95% | 617 | |
BioNTech SE ADR | - | 4.09% | aa.aa | - | - | 1,255 |
iShares Genomics Immunology and Healthcare Index ETF is an exchange traded fund launched and managed by BlackRock Asset Management Canada Limited. It is co-managed by BlackRock Institutional Trust Company, N.A. It invests in public equity markets of global region. It invests in stocks of companies operating across health care, health care equipment and services, pharmaceuticals, biotechnology and life sciences sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index, by using full replication technique. iShares Genomics Immunology and Healthcare Index ETF was formed on April 26, 2022 and is domiciled in Canada.